Kyowa Hakko Bio is a Japanese leading company of bio-technology and fermentation. The company is a global leader with over 60 years of manufacturing expertise and a reputation for rigorous quality assurance. With its innovative fermentation technology built over the years, KYOWA has become a trusted pioneer in the healthcare field, making substantial contributions to the health and well-being of people around the world.
Private/Public:private
Phone:+81-3-5205-7300
Website:http://www.kyowahakko-bio.co.jp/english/
Address:Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan
API/Biologicals Production
API/Biologics development and manufacturing
Reagents/excipients manufactured
Japan
- (23.Jun.2022) Manufacturing Strain of Kyowa Hakko Bio's 2'-Fucosyllactose, a Human Milk Oligosaccharide (HMO), Passed Safety Evaluation in China
- (20.Apr.2022) Kyowa Hakko USA Announces the Appointment of Gerard Adams as Its New President and CEO
- (06.Dec.2021) Notice Regarding Change of President & CEO at Kyowa Hakko Bio